Hyperglucagonaemia and treatment with danazol for systemic lupus erythematosus
Case report
OA: bronze
CC0
⤵ 5 in-corpus citations
AI-generated summary
This paper investigated hyperglucagonemia in systemic lupus erythematosus patients and assessed the efficacy of danazol treatment.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (7)
- Systemic lupus erythematosus: two patients treated with danazol via openalex
- The effect of danazol on anterior pituitary function via openalex
- W2460430351 via openalex
- doi:10.1016/0009-8981(77)90240-6 via openalex
- doi:10.1136/jcp.25.3.266 via openalex
- W2415888241 via openalex
- W97811737 via openalex
Cited by (5)
- Effect of danazol-induced chronic hyperglucagonaemia on glucose tolerance and turnover 1995
- Metabolie effects of danazol 1991
- Glucose tolerance and insulin resistance after danazol treatment 1989
- The treatment of glucocorticosteroid-dependent chronic urticaria with stanozolol 1988
- Elevated plasma glucagon caused by danazol 1987
Source provenance
- openalex
- last seen: 2026-05-11T05:08:23.114259+00:00
- pubmed
- last seen: 2026-10-08T21:45:49.029772+00:00
License: CC0
· commercial use OK